PureTech Health (PRTC) Current Deferred Revenue (2019 - 2021)

PureTech Health (PRTC) has 3 years of Current Deferred Revenue data on file, last reported at $65000.0 in Q4 2021.

• Quarterly Current Deferred Revenue fell 95.58% year-over-year to $65000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $65000.0 (down 95.58% YoY) and the FY2021 annual result came in at $65000.0, down 95.58% from the prior year.
• Current Deferred Revenue retreated to $65000.0 in Q4 2021 per PRTC's latest filing, from $1.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $5.5 million in Q4 2019 and bottomed at $65000.0 in Q4 2021.
• The 3-year median for Current Deferred Revenue is $1.5 million (2020), against an average of $2.3 million.
• The widest annual swing landed in 2020, when Current Deferred Revenue plunged 73.11%; it then sank 95.58% in 2021.
• Tracing PRTC's Current Deferred Revenue over 3 years: stood at $5.5 million in 2019, then plunged by 73.11% to $1.5 million in 2020, then slumped by 95.58% to $65000.0 in 2021.
• Per Business Quant, the three latest PRTC Current Deferred Revenue figures stand at $65000.0 (Q4 2021), $1.5 million (Q4 2020), and $5.5 million (Q4 2019).

Peer Comparison